View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Erlotinib 150, Non-Small Cell Lung Cancer (second- and third-line)
Protocol-ID: 195 V1.0 (Mini), ERLO150, NSCLC (second and third line)Indication(s)
- Lung Carcinoma, Non-Small Cell; ICD-10 C34.-
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 03.11.2014